Dermata Therapeutics Inc (DRMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 1,926 | 1,900 | 1,761 | 1,773 | 2,340 |
| Operating Income | -1,926 | -1,900 | -1,761 | -1,773 | -2,340 |
| Other Income | 79 | 39 | 69 | 72 | 36 |
| Pre-tax Income | -1,848 | -1,862 | -1,692 | -1,701 | -2,304 |
| Net Income Continuous | -1,848 | -1,862 | -1,692 | -1,701 | -2,304 |
| Net Income | $-1,848 | $-1,862 | $-1,692 | $-1,701 | $-2,304 |
| EPS Basic Total Ops | -0.48 | -0.38 | -1.65 | -1.66 | -4.47 |
| EPS Basic Continuous Ops | -0.48 | -0.39 | -1.65 | -1.66 | -4.47 |
| EPS Diluted Total Ops | -0.48 | -0.38 | -1.65 | -1.66 | -4.47 |
| EPS Diluted Continuous Ops | -0.48 | -0.39 | -1.65 | -1.66 | -4.47 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.52 | -1.65 | -1.66 | -4.50 |
| EBITDA(a) | $-1,926 | $-1,900 | $-1,761 | $-1,773 | $-2,340 |